Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 5,801 | 10,331 | 10,738 | 3,236 | 10,641 |
| Gross Profit | 5,801 | 10,331 | 10,738 | 3,236 | 10,641 |
| Operating Expenses | 26,266 | 53,166 | 62,784 | 14,328 | 14,044 |
| Operating Income | -21,465 | -42,834 | -52,045 | -11,092 | -3,403 |
| Interest Expense | 2 | 297 | 162 | 39 | 0 |
| Other Income | 889 | -2,190 | 144 | 43 | 24 |
| Pre-tax Income | -20,579 | -45,321 | -52,064 | -11,087 | -3,379 |
| Income Tax | -59 | -6,150 | -5,638 | N/A | 62 |
| Net Income Continuous | -20,520 | -39,171 | -46,425 | -11,087 | -3,441 |
| Net Income | $-20,520 | $-39,171 | $-46,425 | $-11,087 | $-3,441 |
| EPS Basic Total Ops | -1.60 | -15.16 | -118.91 | -49.85 | -15.02 |
| EPS Basic Continuous Ops | -1.56 | -13.98 | -107.50 | -48.17 | -16.15 |
| EPS Diluted Total Ops | -1.60 | -15.16 | -118.91 | -49.85 | -15.02 |
| EPS Diluted Continuous Ops | -1.56 | -13.98 | -107.50 | -48.17 | -16.15 |
| EPS Diluted Before Non-Recurring Items | -0.98 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-20,078 | $-17,591 | $-15,987 | $-10,956 | $-3,261 |